Risk factors for primary graft dysfunction after lung transplantation

Slides:



Advertisements
Similar presentations
Orlando Petrucci, MD, PhD, Philip R. Khoury, MS, Peter B
Advertisements

The “occasional open heart surgeon” revisited
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Manuel J. Antunes, MD, PhD, DSc 
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Two decades of pediatric lung transplant in the United States: Have we improved?  Farhan Zafar, MD, Jeffrey S. Heinle, MD, Marc G. Schecter, MD, Joseph.
Lobar lung transplantation: One size fits all
The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting  Danny Chu, MD, Faisal.
Mitral stenosis with pulmonary hypertension: We should operate early
Orlando Petrucci, MD, PhD, Philip R. Khoury, MS, Peter B
Outcomes of cardiac surgery in chronic kidney disease
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures  J. Saravana Ganesh, FRCS, Chris.
Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D
The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation  Arman Kilic, MD,
Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.
Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,
Right internal thoracic artery or saphenous vein grafting
Outcomes of surgery for young children with multivessel pulmonary vein stenosis  Luis G. Quinonez, MD, Kimberlee Gauvreau, PhD, Michele Borisuk, NP, Christina.
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Form ever follows function
William M. DeCampli, MD, PhD 
Bilateral pulmonary arterial banding results in an increased need for subsequent pulmonary artery interventions  Ryan R. Davies, MD, Wolfgang A. Radtke,
Phil Botha, MRCS, Dipesh Trivedi, FRCS, Christopher J
Multilevel data analysis: What? Why? How?
Long-term patient and allograft outcomes of renal transplant recipients undergoing cardiac surgery  Rodolfo V. Rocha, MD, Diana Zaldonis, MPH, Vinay Badhwar,
Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort  Leah Backhus, MD, Jonathon Sargent, BS, Aaron.
Should lung transplantation be performed using donation after cardiac death? The United States experience  David P. Mason, MD, Lucy Thuita, MS, Joan M.
Adult-age donors offer acceptable long-term survival to pediatric heart transplant recipients: An analysis of the United Network of Organ Sharing database 
Evaluation of the oxygenation ratio in the definition of early graft dysfunction after lung transplantation  Takahiro Oto, MD, Bronwyn J. Levvey, RN,
The lord of the rings  Antonio Miceli, MD, PhD 
Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease  Matthew E. Oster, MD, Matthew J.
Combined heart-kidney transplant improves post-transplant survival compared with isolated heart transplant in recipients with reduced glomerular filtration.
Competing risks need to be considered in survival analysis models for cardiovascular outcomes  Marianne Huebner, PhD, Martin Wolkewitz, Dr Sc Hum, Maurice.
Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model  Daniel.
David P. Mason, MD, Lillian H. Batizy, MS, Jeffrey Wu, MD, Edward R
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Comparative study of bronchial artery revascularization in lung transplantation  Gösta B. Pettersson, MD, PhD, Karam Karam, MD, Lucy Thuita, MS, Douglas.
Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery  Su-Kiat Chua, MD,
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
Do we need a bibliometrician to know which way the wind is blowing?
A first start for lung transplantation?
The influence of retransplantation on survival for pediatric lung transplant recipients  Ryuichi Waseda, MD, PhD, Alberto Benazzo, MD, Konrad Hoetzenecker,
Arterial lactate before initiation of venoarterial extracorporeal membrane oxygenation for postcardiotomy shock improves postimplant outcome prediction 
Arman Kilic, MD, Eric S. Weiss, MD, MPH, Jeremiah G
Impact of low donor to recipient weight ratios on cardiac transplantation  Senthil Nathan Jayarajan, MD, Sharven Taghavi, MD, Eugene Komaroff, PhD, Abeel.
Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass  Benjamin Medalion, MD, Michael G. Katz, MD,
Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD ( )  Myunghyun Lee, MD, Vivek Rao, MD, PhD  The.
Daniel Kreisel, MD, PhD, Alexander S
The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: An analysis of the United Network for Organ Sharing database 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
The thoracoabdominal saga and heroes
Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Surgical outcomes after cardiac surgery in liver transplant recipients
Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005  Howard K. Song, MD, PhD, Brian S. Diggs,
The continuing challenge of congenital heart disease in China
The impact of concomitant pulmonary hypertension on early and late outcomes following surgery for mitral stenosis  Bo Yang, MD, PhD, Christina DeBenedictus,
The Journal of Thoracic and Cardiovascular Surgery
Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement  Todd M. Dewey,
Apples remain apples NO matter what
Energized lung resections
Preoperative PFTs: The answer is blowing in the wind
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Kalpaj Parekh, MD, Bryan F. Meyers, MD, G
Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks!  W. Hampton Gray, MD, P. Michael.
Definitions of primary graft dysfunction after lung transplantation: Differences between bilateral and single lung transplantation  Takahiro Oto, MD,
Presentation transcript:

Risk factors for primary graft dysfunction after lung transplantation Bryan A. Whitson, MD, Dilip S. Nath, MD, Adam C. Johnson, MD, Adam R. Walker, BS, Matthew E. Prekker, MD, David M. Radosevich, PhD, Cynthia S. Herrington, MD, Peter S. Dahlberg, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 131, Issue 1, Pages 73-80 (January 2006) DOI: 10.1016/j.jtcvs.2005.08.039 Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Prevalence and 90-day survival of patients with grade 3 primary graft dysfunction (PGD). A, Point prevalence of International Society for Heart and Lung Transplantation grade 3 PGD at each individual time during the first 48 hours is represented by the open bars. The cumulative percentage of grade 3 prevalence is shown in the filled bars. B, Percentage of patients dying within 90 days after surgical intervention stratified by whether (filled bars) or not (open bars) the patient had grade 3 PGD at each time point after the operation and as a worst grade 48-hour end point (last set of bars). The differences in 90-day death rates among groups were significantly different (P < .05, χ2 test) at all time points. The Journal of Thoracic and Cardiovascular Surgery 2006 131, 73-80DOI: (10.1016/j.jtcvs.2005.08.039) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Long-term survival stratified by modified primary graft dysfunction grade. Kaplan-Meier actuarial survival curves are stratified by modified International Society for Heart and Lung Transplantation (ISHLT) grade. Patients with grade 3 primary graft dysfunction had a significantly reduced survival compared with those with grade 1 and grade 2 primary graft dysfunction (median survival grade 3, 4.6 years; grade 2, 6.6 years; grade 1, 7.5 years; P = .006, log-rank test). Grade 1 is represented in dark dray, grade 2 is represented in light gray with hatching, and grade 3 is represented in black. The Journal of Thoracic and Cardiovascular Surgery 2006 131, 73-80DOI: (10.1016/j.jtcvs.2005.08.039) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Adjusted odds of severe primary graft dysfunction (PGD). A, Multivariate adjusted odds of PGD according to donor age. Individual points represent the mean odds of groups of 40 patients. The first data grouping was used as the reference. B,Multivariate adjusted odds of PGD according to pulmonary artery (PA) pressure. Individual points represent the mean odds of groups of 40 patients. The first data grouping was used as the reference. The Journal of Thoracic and Cardiovascular Surgery 2006 131, 73-80DOI: (10.1016/j.jtcvs.2005.08.039) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions